Testosterone Replacement Therapy (TRT) is a medical treatment for men with low testosterone levels. As the prevalence of hypogonadism (low testosterone) grows, the demand for TRT products has increased. Here are the top 10 companies that are leading the TRT market, along with detailed insights into their offerings, market presence, and innovations. 1. AbbVie Inc. Overview: AbbVie, a global biopharmaceutical company, is a leader in TRT with its product, AndroGel. AndroGel is a topical gel applied to the skin, which allows testosterone to be absorbed directly into the bloodstream. Key Product: AndroGel: Available in different strengths (1.62% and 1%). It's one of the most prescribed TRT products globally. Market Presence: AbbVie has a strong presence in North America and Europe. The company’s extensive marketing and physician outreach programs have made AndroGel a widely recognized brand. Innovations: AbbVie continues to invest in research and development to improve the